Aandelen in “Diensten aan de gezondheidssector”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Diensten aan de gezondheidssector”

30/03 · 2025 annual results: Equasens reports a solid performance across all financial indicators · Persbericht

30/03 · 2025 annual results: Equasens reports a solid performance across all financial indicators · Persbericht

19/03 · Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026 · Persbericht

18/03 · Illumina and Labcorp expand collaboration to broaden access to precision oncology testing · Persbericht

12/03 · Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors · Persbericht

2/03 · Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results · Persbericht

26/02 · Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer · Persbericht

25/02 · Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference · Persbericht

23/02 · Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide · Persbericht

17/02 · Labcorp Announces 2025 Fourth Quarter and Full Year Results · Persbericht

11/02 · Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care · Persbericht

10/02 · Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share · Persbericht

10/02 · Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization · Persbericht

9/02 · Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors · Persbericht

5/02 · Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year revenue of €236.5m (+9.1% as reported) · Persbericht

2/02 · Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease · Persbericht

22/01 · Promethean named 'Company of the Year' at BETT Awards 2026 · Persbericht

21/01 · Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year · Persbericht

20/01 · Promethean ActivSuite Expands Compatibility with ChromeOS Integration · Persbericht

15/01 · Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 · Persbericht

15/01 · Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect · Persbericht

Mijn selecties